| scholarly article | Q13442814 |
| P2093 | author name string | Ellen A Cannady | |
| Chris Ward | |||
| David S Small | |||
| Jeffrey G Suico | |||
| Demetrio Ortega | |||
| Jane Royalty | |||
| Qun Lin | |||
| Kenneth Ruterbories | |||
| Brian W Pack | |||
| William F Annes | |||
| Aktham Aburub | |||
| Chris Hinds | |||
| Boris Czeskis | |||
| Syeda L Begum | |||
| P2860 | cites work | Novel strategies for microdose studies using non-radiolabeled compounds | Q37846274 |
| Rationale for cholesteryl ester transfer protein inhibition | Q38003957 | ||
| Update on the Discovery and Development of Cholesteryl Ester Transfer Protein Inhibitors for Reducing Residual Cardiovascular Risk | Q38128624 | ||
| Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial. | Q38481069 | ||
| High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study | Q40070458 | ||
| Human absorption, distribution, metabolism and excretion properties of drug molecules: a plethora of approaches | Q41880361 | ||
| Single dose pharmacokinetics and bioavailability of methadone in man studied with a stable isotope method | Q42671123 | ||
| Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease | Q42807626 | ||
| Simultaneous oral therapeutic and intravenous ¹⁴C-microdoses to determine the absolute oral bioavailability of saxagliptin and dapagliflozin | Q43244925 | ||
| Sensitivity-based analytical approaches to support human absolute bioavailability studies | Q43870165 | ||
| Practical and efficient strategy for evaluating oral absolute bioavailability with an intravenous microdose of a stable isotopically-labeled drug using a selected reaction monitoring mass spectrometry assay. | Q46013390 | ||
| Use of microdosing to predict pharmacokinetics at the therapeutic dose: experience with 5 drugs | Q48665583 | ||
| Calculation and mitigation of isotopic interferences in liquid chromatography-mass spectrometry/mass spectrometry assays and its application in supporting microdose absolute bioavailability studies | Q84010553 | ||
| A Novel Double-Tracer Technique to Characterize Absorption, Distribution, Metabolism and Excretion (ADME) of [14C]Tofogliflozin After Oral Administration and Concomitant Intravenous Microdose Administration of [13C]Tofogliflozin in Humans | Q86393023 | ||
| Evacetrapib is a novel, potent, and selective inhibitor of cholesteryl ester transfer protein that elevates HDL cholesterol without inducing aldosterone or increasing blood pressure | Q24624286 | ||
| Absolute bioavailability in man of N-acetylprocainamide determined by a novel stable isotope method | Q28217722 | ||
| Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials | Q29617910 | ||
| Pharmacokinetics of fexofenadine: evaluation of a microdose and assessment of absolute oral bioavailability | Q34105874 | ||
| Meta-analysis: Statin Therapy Does Not Alter the Association Between Low Levels of High-Density Lipoprotein Cholesterol and Increased Cardiovascular Risk | Q34155924 | ||
| Efficacy, safety, tolerability, and pharmacokinetic profile of evacetrapib administered as monotherapy or in combination with atorvastatin in Japanese patients with dyslipidemia | Q34418302 | ||
| The use of isotopes in the determination of absolute bioavailability of drugs in humans | Q34550493 | ||
| Plasma cholesteryl ester transfer protein | Q34662720 | ||
| Effects of the cholesteryl ester transfer protein inhibitor evacetrapib on lipoproteins, apolipoproteins and 24-h ambulatory blood pressure in healthy adults | Q34823459 | ||
| A Multidose Study to Examine the Effect of Food on Evacetrapib Exposure at Steady State | Q35953512 | ||
| Bioavailability and its assessment. | Q35985413 | ||
| Workshop report and follow-up--AAPS Workshop on current topics in GLP bioanalysis: Assay reproducibility for incurred samples--implications of Crystal City recommendations | Q37453124 | ||
| P433 | issue | 6 | |
| P921 | main subject | bioavailability | Q461809 |
| P304 | page(s) | 238-244 | |
| P577 | publication date | 2015-12-07 | |
| P1433 | published in | Journal of Labelled Compounds and Radiopharmaceuticals | Q3186923 |
| P1476 | title | Absolute bioavailability of evacetrapib in healthy subjects determined by simultaneous administration of oral evacetrapib and intravenous [(13) C8 ]-evacetrapib as a tracer | |
| P478 | volume | 59 |
Search more.